| Dopamine receptors and neurodegeneration C Rangel-Barajas, I Coronel, B Florán Aging and disease 6 (5), 349, 2015 | 291 | 2015 |
| Dopamine D4 receptor, but not the ADHD-associated D4. 7 variant, forms functional heteromers with the dopamine D2S receptor in the brain S González, C Rangel-Barajas, M Peper, R Lorenzo, E Moreno, F Ciruela, ... Molecular psychiatry 17 (6), 650-662, 2012 | 132 | 2012 |
| L-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata C Rangel-Barajas, I Silva, LM Lopéz-Santiago, J Aceves, D Erlij, B Florán Neurobiology of disease 41 (1), 51-61, 2011 | 101 | 2011 |
| Adenosine A1 receptors control dopamine D1-dependent [3H] GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat JA B Floran, C Barajas, L Floran, D Erlij Neuroscience 115 (3), 743-751, 2002 | 67 | 2002 |
| D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat R Cruz-Trujillo, A Avalos-Fuentes, C Rangel-Barajas, F Paz-Bermúdez, ... Neuropharmacology 67, 370-378, 2013 | 60 | 2013 |
| Dysregulation of corticostriatal connectivity in Huntington’s disease: a role for dopamine modulation C Rangel-Barajas, GV Rebec Journal of Huntington's disease 5 (4), 303-331, 2016 | 57 | 2016 |
| Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT7 receptors BB García-Iglesias, ME Mendoza-Garrido, G Gutiérrez-Ospina, ... Neuropharmacology 71, 216-227, 2013 | 54 | 2013 |
| The effects of sigma (σ1) receptor‐selective ligands on muscarinic receptor antagonist‐induced cognitive deficits in mice M Malik, C Rangel‐Barajas, N Sumien, C Su, M Singh, Z Chen, ... British journal of pharmacology 172 (10), 2519-2531, 2015 | 45 | 2015 |
| 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [3H]-GABA release and [3H]-cAMP production in substantia nigra pars reticulata of … C Rangel-Barajas, I Silva, M García-Ramírez, E Sánchez-Lemus, L Floran, ... Neuropharmacology 55 (5), 704-711, 2008 | 36 | 2008 |
| Bitropic D3 dopamine receptor selective compounds s potential antipsychotics R R. Luedtke, C Rangel-Barajas, M Malik, D E. Reichert, R H. Mach Current pharmaceutical design 21 (26), 3700-3724, 2015 | 28 | 2015 |
| Overview of Huntington's disease models: neuropathological, molecular, and behavioral differences C Rangel‐Barajas, GV Rebec Current protocols in neuroscience 83 (1), e47, 2018 | 25 | 2018 |
| Characterization of [3H]LS‐3‐134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand C Rangel‐Barajas, M Malik, M Taylor, KA Neve, RH Mach, RR Luedtke Journal of neurochemistry 131 (4), 418-431, 2014 | 22 | 2014 |
| Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat A Avalos-Fuentes, S Albarrán-Bravo, S Loya-Lopéz, H Cortés, ... Neurobiology of Disease 74, 336-346, 2015 | 21 | 2015 |
| Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compounds C Rangel-Barajas, M Malik, S Vangveravong, RH Mach, RR Luedtke Neuropharmacology 83, 18-27, 2014 | 21 | 2014 |
| Cortico-striatal cross-frequency coupling and gamma genesis disruptions in Huntington’s disease mouse and computational models S Naze, J Humble, P Zheng, S Barton, C Rangel-Barajas, GV Rebec, ... ENeuro 5 (6), 2018 | 20 | 2018 |
| Pathophysiology of L-Dopa Induced Dyskinesia—Changes in D1/D3 Receptors and Their Signaling SA Bravo, C Rangel-Barajas, BF Garduño A Synopsis of Parkinson's Disease, 119, 2014 | 16 | 2014 |
| Sex-specific timelines for adaptations of prefrontal parvalbumin neurons in response to stress and changes in anxiety-and depressive-like behaviors E Woodward, C Rangel-Barajas, A Ringland, ML Logrip, L Coutellier ENeuro 10 (3), 2023 | 14 | 2023 |
| Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward V Iyer, C Rangel-Barajas, TJ Woodward, A Kulkarni, L Cantwell, ... Pharmacological research 185, 106474, 2022 | 14 | 2022 |
| Altered excitatory transmission in striatal neurons after chronic ethanol consumption in selectively bred crossed high alcohol-preferring mice C Rangel-Barajas, SL Boehm II, ML Logrip Neuropharmacology 190, 108564, 2021 | 14 | 2021 |
| Striatal network modeling in Huntington’s Disease A Ponzi, SJ Barton, KD Bunner, C Rangel-Barajas, ES Zhang, BR Miller, ... PLoS computational biology 16 (4), e1007648, 2020 | 12 | 2020 |
